The National Institute of Health said it would establish a base for conducting cohort studies to support the development of diagnostics and treatment for dementia.The NIH under the Korea Disease Control and Prevention Agency (KDCA) plans to gather data from dementia patients or people at high risk o
The health authorities need to improve reimbursement and treatments for patients suffering from pulmonary hypertension in early-stage as the disorder ends with a low survival rate.At a National Assembly workshop, Professor Park Jae-hyeong of the Department of Cardiology at Chungnam National Universi
Novo Nordisk said Thursday that its growth hormone formulation Norditropin (ingredient: somatropin) took the largest market share in 27 major countries in June. According to various international market research firms, including IQVIA and GERS, Norditropin dominated the growth hormone market in 27 c
The Korean Society of Nephrology (KSN) has held a symposium jointly with the European Dialysis and Transplant Association (EDTA) to share experiences and strategies in responding to Covid-19 for patients with chronic kidney disease.Professor Luuk Hilbrands of Radboud University Medical Center, Nethe
The Korean government will provide comprehensive support for the health industry and promote collaboration with international organizations to realize its goal of becoming a global vaccine hub, a top official said Wednesday.At the Global Bio Conference organized by the Ministry of Food and Drug Safe
Advanced regulatory science is needed to provide better biopharmaceutical products for people amid pandemics, such as Covid-19, former U.S. Food and Drug Administration Commissioner Margaret Hamburg said on Tuesday.At the Global Bio Conference held by the Ministry of Food and Drug Safety, Hamburg, v
HLB said its Chinese partner would showcase the efficacy of its anticancer drug candidate, rivoceranib, for various indications by presenting 13 study results at the European Society for Medical Oncology (ESMO) conference.The company expects Jiangsu Hengrui Medicine, which holds the marketing rights
JW Bioscience has signed a non-exclusive agreement to transfer its patented technology of multiple-biomarker complement factor b (CFB) and carbohydrate antigen 19-9 (CA19-9) to Sweden's Immunovia AB.The company developed the technology to detect pancreatic cancer early with a diagnostic kit using th
The government should provide more support and human resources for the bio-health industry while working out policies and global strategies to better deal with infectious diseases, such as Covid-19, an expert said Monday.“In conclusion, no one is safe until everyone is safe, and we must prepare and
A Korea University Guro Hospital (KUGH) research team received Orthopedic Video Theater (OVT) Award at the annual meeting of the American Academy of Orthopaedic Surgeons between Aug. 31 and Sept. 4 in San Francisco, Calif.The research team, led by Professors Oh Jong-keon and Cho Jae-woo of the Depar
Thoracic surgeons had long conducted surgeries to treat heart diseases. In the early 2000s, the advent of drug-eluting stents coated with drugs that prevent blood clots dramatically improved the treatment’s efficiency and patients’ convenience.Stenting is one of the interventional procedures most us
Samsung Bioepis said it has confirmed the safety and long-term efficacy profiles of Ontruzant (ingredient: trastuzumab), a biosimilar of cancer medicine trastuzumab, in a five-year follow-up study.The company will present the results of its long-term study comparing Ontruzant ) and reference medicin
Hanmi Pharmaceutical has decided not to give up on its anti-nicotine therapy and challenge Pfizer’s original treatment, Champix (ingredient: varenicline tartrate), once again.Earlier, the Korean company successfully released a treatment with the modified salt base but failed as it lost in the patent
Merck Biopharma Korea has shared its latest findings and the study results of Mavenclad (ingredient: cladribine) in treating multiple sclerosis patients who received the Covid-19 vaccine at an online meeting held on Thursday.Professor Dimitrios Karussis of Neurology at Hebrew University, Israel, des
Samsung Bioepis said it confirmed its Lucentis (ingredient: ranibizumab) biosimilar, Byooviz, as an effective and valuable option for patients with neovascular age-related macular degeneration (nAMD) in phase 3 clinical trial.The new study results will be presented at an online meeting hosted by the
Maria Trading, a trusted distributor of medical aesthetics products in the United Arab Emirates (UAE), has signed an agreement with a Korean company, Coous Global, to supply Coresculpt 2CH, which helps build up muscles.Maria Trading was founded in 2004 and has since delivered promising aesthetics de
Medpacto’s research team has developed a novel way to decrease the size of a drug down to nanoparticles and encapsulate it to penetrate the pancreatic cancer tissue easier.The company’s size-switchable nanosystem is designed to deliver two different drugs sequentially for enhanced chemotherapy in ca
Huons said it would conduct a test to verify how strong the Russian Sputnik V Covid-19 vaccine can protect people against the Delta variant.The company and Korea University's Biosafety Center plan to confirm the preventive efficacy against the Delta variant with an animal model using a hamster for t
Samsung Medical Center said Wednesday that it has succeeded subretinal injection of gene therapy Luxturna (ingredient: voretigene neparvovec) in a patient with inherited retinal degeneration for the first time in Korea.Luxturna received approval from the U.S. Food and Drug Administration in 2017 as
JW Bioscience’s technology using tryptophanyl tRNA synthetase (WRS) as a biomarker for early diagnosis of sepsis, or blood poisoning, has been registered as a source technology from the European Patent Office.The company has secured an advantageous position in the global in-vitro diagnostic market w